Cargando…
Role of cellular reprogramming and epigenetic dysregulation in acquired chemoresistance in breast cancer
Acquired resistance to chemotherapy is a major limitation in clinical treatment for breast cancer. Accumulating evidence from in vitro, in vivo and clinical studies suggest that acquired chemoresistance is progressive, multifactorial and involve genetic and epigenetic aberrations. Among various mech...
Autores principales: | Ponnusamy, Logeswari, Mahalingaiah, Prathap Kumar S., Chang, Yu-Wei, Singh, Kamaleshwar P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992622/ https://www.ncbi.nlm.nih.gov/pubmed/35582717 http://dx.doi.org/10.20517/cdr.2018.11 |
Ejemplares similares
-
Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells
por: Mahalingaiah, Prathap Kumar S., et al.
Publicado: (2016) -
Chronic Oxidative Stress Increases Growth and Tumorigenic Potential of MCF-7 Breast Cancer Cells
por: Mahalingaiah, Prathap Kumar S., et al.
Publicado: (2014) -
Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells
por: Chang, Yu-Wei, et al.
Publicado: (2017) -
The role of metabolic reprogramming in pancreatic cancer chemoresistance
por: Liu, Chang, et al.
Publicado: (2023) -
Cellular reprogramming and epigenetic rejuvenation
por: Simpson, Daniel J., et al.
Publicado: (2021)